SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-20-036930
Filing Date
2020-11-13
Accepted
2020-11-13 16:16:09
Documents
2
Period of Report
2020-11-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ea129864_8k.htm 8-K 16984
2 ADITXT PROVIDES BUSINESS UPDATE AND FILES THIRD QUARTER 2020 10-Q ex99_1.htm EX-99.1 5767
  Complete submission text file 0001213900-20-036930.txt   23907
Mailing Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354
Business Address 11161 ANDERSON STREET SUITE 105-10014 LOMA LINDA CA 92354 909-488-0844
ADiTx Therapeutics, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 201311685
SIC: 2834 Pharmaceutical Preparations